November 25, 2013 — The blood-thinning drug Xarelto (rivaroxaban) has been associated with a higher risk of bleeding in certain patients, according to Medscape. Researchers linked Xarelto to a nearly 3-fold increased risk of bleeding for acutely ill patients and a 4-fold increased risk of major bleeding in patients with Acute Coronary Syndrome (ACS).
Dr. Partha Sardar of New York Medical College presented the results of his research at the American Heart Association 2013 Scientific Sessions. The conclusions were based on data from 48 clinical trials involving five new blood-thinning drugs — Xarelto, Pradaxa, Eliquis, Lixiana, and darexaban. All of them have been introduced since 2010.
Researchers wanted to know how they performed compared to each other and also compared to warfarin and heparin, which have been mainstays of anticoagulant therapy for over 50 years.
Xarelto was also shown to reduce the risk of bleeding for patients at risk of pulmonary embolism (PE) or venous thromboembolism (VTE). However, Xarelto and other blood-thinners were significantly more likely to cause bleeding in patients with acute coronary syndrome (ACS), hip surgery, and acutely ill patients taking a blood-thinner as a prophylaxis against blood clots.
Higher risk of bleeding for new blood-thinners:
- Hip surgery: 1.43-fold increased rate of major bleeding
- Acute Coronary Syndrome (ACS): 3.27-fold increased rate of major bleeding
- Medically ill thromboprophylaxis: 2.79-fold increased rate of major bleeding
Do I have a Xarelto Lawsuit?
The Schmidt Firm, PLLC is currently accepting Xarelto induced injury cases in all 50 states. If you or somebody you know has been injured by Xarelto, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.